ọgwụgwọ Ezubere ịnye ọgwụ maka ọrịa kansa

Ọgwụgwọ Ezubere ịnyefe ọgwụ maka ọrịa kansa

Isiokwu a na-enye nkọwa zuru ezu nke ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ọrịa kansa, na-enyocha usoro ya, uru ya, ihe ịma aka ya na ntụzịaka ya n'ọdịnihu. Anyị na-enyocha ụzọ dị iche iche, gụnyere nanotechnology, mgbochi-ọgwụ conjugates, na usoro ọgwụgwọ mkpụrụ ndụ ihe nketa, na-enyocha ngwa ụlọ ọgwụ ha na nyocha na-aga n'ihu. Mụta maka uru nke ọgwụgwọ ezubere iche ma e jiri ya tụnyere chemotherapy ọdịnala yana mbọ a na-aga n'ihu iji melite nrụpụta yana belata mmetụta ndị ọzọ.

Usoro nke nnyefe ọgwụ ezubere iche

Nnyefe ọgwụ dabere na teknụzụ Nanotechnology

Nanotechnology na-arụ ọrụ dị mkpa na ya ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ọrịa kansa. Nanoparticles, n'ihi obere nha na ikike ịbanye n'ime anụ ahụ, nwere ike ibuga ọgwụ chemotherapeutic ozugbo na mkpụrụ ndụ etuto, na-ebelata ikpughe na anụ ahụ dị mma. A na-enyocha ụdị nanoparticles dị iche iche, gụnyere liposomes, polymeric nanoparticles, na inorganic nanoparticles, maka ikike ha nwere n'ịkwalite nrụpụta ọgwụ na ibelata nsị. Dịka ọmụmaatụ, liposomal doxorubicin (Doxil) bụ usoro nnyefe ọgwụ ezubere iche nke ụlọ ọgwụ kwadoro nke na-ebelata cardiotoxicity ma e jiri ya tụnyere doxorubicin. Nnyocha na-aga n'ihu n'ịkwalite nhazi nanoparticle maka nleba anya etuto ahụ na mwepụta ọgwụ. Ụlọ ọrụ nyocha ọrịa kansa Shandong Baofa na-etinye aka n'ịchọpụta ọganihu ọhụrụ na mpaghara a.

Njikọ Antibody-Drug Conjugates (ADCs)

ADC na-anọchite anya atụmatụ ọzọ dị mkpa na ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ọrịa kansa. Ndị ọrụ ọgwụgwọ ndị a nwere ọgwụ cytotoxic jikọtara ya na mgbochi monoclonal nke na-elekwasị anya kpọmkwem na mkpụrụ ndụ kansa. Ụzọ a na-eme ka a hụ na a na-ebuga ọgwụ ahụ na-ahọrọ na mkpụrụ ndụ cancer, na-ebelata mmetụta ndị a na-atụghị anya ya na imeziwanye usoro ọgwụgwọ ọgwụgwọ. Ọmụmaatụ nke ADC ndị akwadoro gụnyere trastuzumab emtansine (Kadcyla) maka ọrịa kansa ara HER2 na brentuximab vedotin (Adcetris) maka lymphoma Hodgkin. Nchọpụta na-aga n'ihu na-elekwasị anya n'ịkwalite ụdị mgbochi mmadụ na-ezubere iche yana ịmepụta ụgwọ ọrụ cytotoxic ọhụrụ.

Usoro ọgwụgwọ Gene

Usoro ọgwụgwọ Gene na-enye ohere dị mma maka ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ọrịa kansa. Usoro a gụnyere imegharị mkpụrụ ndụ ihe nketa n'ime mkpụrụ ndụ kansa iji gbochie uto etuto ma ọ bụ kwalite ikike sistemu ahụ ji alụso ọrịa ọgụ ọgụ. A na-ejikarị vectors na-ebufe mkpụrụ ndụ ihe nketa ọgwụgwọ na sel. Nnyocha ndị ọzọ na-enyocha usoro ndezi mkpụrụ ndụ ihe nketa dị ka CRISPR-Cas9 maka mgbanwe mkpụrụ ndụ ziri ezi yana nkwalite arụmọrụ.

Uru na ihe ịma aka nke nnyefe ọgwụ ezubere iche

Usoro nnyefe ọgwụ ezubere iche na-enye ọtụtụ uru karịa ọgwụgwọ chemotherapy, gụnyere arụmọrụ ka mma, mbelata nsị, yana nkwalite nnabata onye ọrịa. Otú ọ dị, ihe ịma aka ka dị, gụnyere mmepe nke nguzogide ọgwụ ọjọọ, mkpa ezubere maka etuto ahụ ka mma, na ọnụ ahịa ọgwụgwọ ndị a dị elu.

Tebụl 1: Tụnyere usoro nnyefe ọgwụ ezubere iche

Ntuziaka ọdịnihu na nnyefe ọgwụ ezubere iche maka ọrịa kansa

Nnyocha na-aga n'ihu na-elekwasị anya n'ịkọba njedebe nke usoro nnyefe ọgwụ ezubere iche ugbu a yana ịmepụta ụzọ ọhụrụ. Nke a na-agụnye imeziwanye ihe ezubere iche ọgwụ, ịkwalite usoro mwepụta ọgwụ, na imeri nguzogide ọgwụ. A na-atụ anya na njikọta nke ọtụtụ atụmatụ ezubere iche, usoro ọgwụgwọ ahaziri onwe ya, na mmepe nke usoro nnyefe ọgwụ nwere ọgụgụ isi ga-abawanye uru na nchekwa. ọgwụgwọ ezubere iche maka nnyefe ọgwụ maka ọrịa kansa. Nnyocha ndị ọzọ na ụlọ ọrụ dị ka Shandong Baofa Cancer Research Institute dị oke mkpa n'ịkwalite mpaghara a.

Nkwuputa: Ozi a bụ naanị maka ebumnuche nkuzi na ekwesighi ịtụle ndụmọdụ ahụike. Gwa onye ọkachamara ahụike oge niile maka nsogbu ahụike ọ bụla ma ọ bụ tupu ịme mkpebi ọ bụla metụtara ahụike ma ọ bụ ọgwụgwọ gị.

Ntụaka: (Gụnye ntụaka ndị dị mkpa ebe a, na-ezo aka kpọmkwem ọmụmụ na akwụkwọ na-akwado ozi ewepụtara. Jiri ụdị ngụ na-agbanwe agbanwe.)